Contact
searchSearch
HMP Global
Login

March 2019

Pathways in Practice
Considerations in the Development of Ovarian Cancer Pathways
04/08/2019
In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular disease state, and...
In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular disease state, and...
In...
04/08/2019
Journal of Clinical Pathways
Editor's Page
Optimizing Resource Utilization and the Need for Enhanced Value Frameworks
03/14/2019
Winston Wong, PharmD
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
Continued innovations in oncology hold the promise of survival improvements. However, new treatments introduce significant challenges for patients, such as higher out-of-pocket expenses and new toxicities. Likewise,...
...
03/14/2019
Journal of Clinical Pathways
Clinical Pathways Forum
Leveraging Data Science and Analytics Tools to Glean Actionable Data From Clinical Pathways
03/14/2019
Mishellene McKinney, MHA, RN, OCN
Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals now totaling over 12 institutions from across the United States and Canada who are utilizing clinical pathways in their...
Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals now totaling over 12 institutions from across the United States and Canada who are utilizing clinical pathways in their...
...
03/14/2019
Journal of Clinical Pathways
PATIENT PERSPECTIVE
How Pathways Can Support Reimbursement for Personalized Decision Making and Care Planning
03/13/2019
Alan J. Balch, PhD, MSc
The ideal way to manage the utilization of health care resources in an era of value-based and precision medicine is to require and provide reimbursement for personalized decision making and care planning with...
The ideal way to manage the utilization of health care resources in an era of value-based and precision medicine is to require and provide reimbursement for personalized decision making and care planning with...
The...
03/13/2019
Journal of Clinical Pathways
Business of Pathways
Eliminating Low-Value Health Care: Where Pathways Approaches Have Succeeded
03/13/2019
Ira Klein, MD, MBA, FACP
Low-value health care continues to put stress on the US economy, as 20% to 40% of all health spending is designated as wasteful. To date, there have been few broad and sustained efforts to reign in wasteful...
Low-value health care continues to put stress on the US economy, as 20% to 40% of all health spending is designated as wasteful. To date, there have been few broad and sustained efforts to reign in wasteful...
...
03/13/2019
Journal of Clinical Pathways
Clinical Pathways GPS
Centers of Excellence: Criteria and Comprehensive Clinical Pathways
03/13/2019
Matthew Pakizegee, PharmD, MS; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
The Center of Excellence (CoE) model of care is an excellent approach to the growing need for disease-based medical management of chronic-type conditions with its multidisciplinary team approach and dedication to...
The Center of Excellence (CoE) model of care is an excellent approach to the growing need for disease-based medical management of chronic-type conditions with its multidisciplinary team approach and dedication to...
The...
03/13/2019
Journal of Clinical Pathways
Pharma Insights
Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model
03/13/2019
Maureen Hennessey, PhD, CPCC, CPHQ; Larry Blandford, PharmD; Linda Bolland, PharmD, MBA
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The...
03/13/2019
Journal of Clinical Pathways
Tools for Transformation
First Things First: Deciding Why Your Practice Is Implementing Pathways
03/13/2019
Gordon Kuntz
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon...
03/13/2019
Journal of Clinical Pathways
Research Reports
Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients
03/13/2019
Chenguang Zhang, MS; Yordanka N. Koleva, PhD; Jerrold Yeo, PsyD; Lisa C. Solursh-Abbrecht, PsyD; Nakhle Saba, MD; Hana Safah, MD
Abstract: Hematopoietic stem cell transplant (HSCT) for blood and bone marrow disorders is a costly procedure that requires complex treatment regimens. In addition to disease-related factors, comorbidity and...
Abstract: Hematopoietic stem cell transplant (HSCT) for blood and bone marrow disorders is a costly procedure that requires complex treatment regimens. In addition to disease-related factors, comorbidity and...
...
03/13/2019
Journal of Clinical Pathways
Perspectives
Advocating for New Patient-Centered Tools for Value-Based Treatment Choices in Oncology
03/13/2019
Henry A. Glick, PhD; Jalpa A. Doshi, PhD; Ellen Miller-Sonet, MBA, JD; Justin T. Puckett
Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...
Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...
...
03/13/2019
Journal of Clinical Pathways
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use